NSPR · InspireMD, Inc.
$0.70
-0.01 (-1.41%)
At close · Jul 17
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has an accumulated deficit as of March 31, 2026, as well as a history of net losses and negative operating cash flows. The Company expects to continue incurring losses and negative cash flows from operations until the Company expands its commercial revenue to a scale that funds its commercial resources, development activities and support functions. As a result of these expected losses and negative cash flows from operations, along with the Company's current cash position, the Company does not have sufficient resources to fund operations for at least the next 12 months. Therefore, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$32.86M
Shares
46,838,962
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.70
Open$0.72
Day$0.70–0.72
52W$0.63–2.93
Avg vol 30d117K
Short int74K · 0.2% float · 1.0d
Short vol45%
Last earningsMay 4, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Aug 2, 2026
Est · unconfirmed
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.8 · elevated
Equity put/call 0.73
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−55%
below
Price vs 50-day avg
−18%
below
RSI (14)
39
neutral
MACD trend
Positive
52-week position
3%
near low
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−57%
trailing
YTD return
−61%
this year
Relative strength
−65%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Flat
3 of 35 funds reported for Jun 30 · net 0 sh shares
Insider flow
Accumulating
Net +$342.9K over 90 days · 20% sells
Short interest
Rising
0.16% of float · ▲ +41.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
35 holders — mid 3-yr range
Squeeze score
32
low risk · 0–100
Fundamentals
Revenue growth
−18%
Y/Y
Gross margin
115%
expanding
EPS growth
0%
Y/Y
Free cash flow
$-36.8M
Balance sheet
$5.2M
net cash
Quant / Vol
risk profile
Volatility
60%
annualized · 1-yr
Max drawdown
−76%
past year
ATR
7.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−55%
Bearish
Price vs 50-day avg
−18%
Bearish
RSI (14)
39
Neutral
MACD trend
Positive
Bullish
52-week position
3%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Flat
3 of 35 funds reported for Jun 30 · net 0 sh shares
Insider flow
Accumulating
Net +$342.9K over 90 days · 20% sells
Short interest
Rising
0.16% of float · ▲ +41.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
35 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 3%
52-wk high $3
vs 200-day avg -55%
vs 50-day avg -18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| cumulative carotid procedures utilizing CGuard Prime | 500 | since launch through Q4 FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NSPR
this stock
InspireMD, Inc.
|
$32.86M | -60.7% | -18.0% | — | 0.2% |
|
ABT
Abbott Laboratories
|
$175.37B | -19.2% | +5.7% | 28.2 | 1.3% |
|
SYK
Stryker Corp
|
$122.63B | -8.7% | +11.2% | 37.0 | 1.8% |
|
MDT
Medtronic plc
|
$106.50B | -12.7% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.44B | -53.8% | +5.5% | 18.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NSPR | -2.8% | -5.4% | -56.8% | +0.0% | -60.7% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | -1.2% | -5.7% | -64.6% | +0.5% | -69.7% |